Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Funding Opportunity Announcements

Partnerships for Environmental Public Health (PEPH)

bar graph being viewed through magnifying glass

As a network, PEPH highlights funding opportunity announcements from NIEHS, from other institutes and centers (ICs) at the National Institutes of Health (NIH) and from other Federal partners. This section lists and describes the various funding opportunity announcements that are PEPH-related. This list will change as new funding opportunity announcements are released and others close.

NIEHS encourages investigators to submit project applications using the unsolicited research grant process (e.g., R01s). Unsolicited, investigator-initiated proposals are sent to NIH for review at the Center for Scientific Review (CSR). There are many Integrated Review Groups (IRGs) at CSR; however, those most likely to be appropriate for PEPH-related unsolicited applications include the Population Sciences and Epidemiology IRG and the Healthcare Delivery and Methodologies IRG.

When preparing your proposal, we highly encourage you to do the following:

Current Available Funding Opportunities

Application Due Date Oct 24 2021
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)

Supports a cohort of early career, independent investigators from diverse backgrounds conducting research in the NIH mission areas. The long-term goal of this program is to enhance diversity in the biomedical research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of promising postdoctoral researchers from diverse backgrounds from their mentored, postdoctoral research positions to independent, tenure-track or equivalent research-intensive faculty positions. The MOSAIC K99/R00 program will provide independent NIH research support before and after this transition to help awardees launch successful, independent research careers. This funding opportunity announcement is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to PAR-21-272. Applicants proposing basic science experimental studies involving humans, should apply to PAR-21-273.

Deadline: October 24, 2021

Application Due Date Nov 01 2021
Notice of Special Interest (NOSI): Research Supplements to Promote Re-entry and Reintegration Into Health-related Research Careers (Admin Supp - Clinical Trial Not Allowed)

Provides support for a mentored research training experience for individuals with high potential to re-enter or re-integrate into an active research career, after an interruption for family responsibilities or other qualifying circumstances. This program encourages reentry and reintegration administrative supplement applications to existing NIH research grants to support full- or part-time mentored research experiences by these individuals. The supplement grants are intended to provide these scientists an opportunity to update or extend their research skills and knowledge and prepare them to reestablish their careers in basic biomedical, behavioral, clinical, translational, or social science research. Reentry supplements provide research training opportunities to individuals with doctoral degrees who have had career interruptions of at least six months and no more than eight years. Reintegration supplements allow postdoctoral and predoctoral students the opportunity to transition to a new, safe, and supportive research environment.

Deadlines: November 1, 2021; December 1, 2021

Application Due Date Nov 03 2021
Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Provides research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country who holds a junior faculty position at a low-or middle-income country academic or research institution. This FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA, Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed). NIEHS is interested in applications that address or seek to understand how exposures to toxic environmental insults alter biologic processes, are linked to disease initiation, progression or morbidity, and activities that lead to the development of prevention and intervention strategies to reduce environmentally induced diseases in low- and middle-income countries. Topics and disease outcomes of particular interest include airway diseases, cardiovascular disease and neurological disorders, children’s environmental health and the unique vulnerability of developing children to harmful environmental exposures including outcomes such as low birth weight or premature birth, and research exploring exposures during early life stages or critical windows of susceptibility that may directly or indirectly affect the risk of developing disease.

Deadline: November 3, 2021

Letter of Intent: Due 30 days prior to the application due date

Application Due Date Nov 09 2021
Autism Centers of Excellence (ACE): Networks (R01 Clinical Trial Optional)

Supports research that will lead to better understanding of the causes and mechanisms underlying autism spectrum disorders, improved efficiency of methods of early identification and diagnosis, and more innovative and cost-effective services for individuals with autism spectrum disorders across their lifespan. ACE Networks consist of multiple sites focusing on a specific topic of research. Each network will submit one R01 application that includes subawards to the collaborating sites. An ACE Network application must require multiple sites for optimal design and conduct of the study. ACE Centers (Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)) must support major multidisciplinary research programs, consisting of interdependent and interrelated research projects. Meaningful and committed interactions among the disciplines must be evident. Each project must have goals and objectives that focus on the common unifying theme that integrates the projects. Applications to both FOAs must include a Plan for Enhancing Diverse Perspectives.

Deadline: November 9, 2021

Letter of Intent: Due 30 days prior to the application due date

Application Due Date Nov 10 2021
Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)

Solicits Phase I (R43), Phase II, and Fast-track (R44) Small Business Innovative Research grant applications from small business concerns in collaboration with environmental science researchers to develop novel tools, activities, or materials to build environmental health literacy for a variety of groups, including community members, health care and public health professionals, educators, and students of all ages. See Innovative Approaches for Improving Environmental health Literacy (R41/R42 Clinical Trial Not Allowed) which solicits Phase I (R41), Phase II (R42), and Fast-track (R42) Small Business Technology Transfer grant applications. As part of its Partnerships for Environmental Public Health (PEPH) program, NIEHS is interested in developing tools that build capacity, improve environmental health literacy, and support citizen science endeavors. In addition, there is a need for improved approaches for communicating environmental health science concepts for diverse audiences, including K-12 education, undergraduate and graduate education, and information for health care professionals. These approaches or resources should be fit-for-purpose to meet the needs of the following audiences: community members, health care and public health professionals, educators, and students of all ages.

Deadline: November 10, 2021

Letter of Intent: October 10, 2021

Application Due Date Nov 15 2021
Mobile Health: Technology and Outcomes in Low- and Middle-Income Countries (R21/R33 – Clinical Trial Optional)

Encourages exploratory and developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries that utilize new or emerging technology, platforms, systems, or analytics to improve health outcomes. Institutions from both U.S. and low- and middle-income countries are eligible to apply to this funding opportunity, and broad partnerships are strongly encouraged. While it is not required (although it is encouraged) for applications submitted to this announcement by low- and middle-income country institutions to have U.S. partners, all applications submitted to this announcement by U.S. institutions are required to involve low- and middle-income country researchers as key personnel. Areas of interest to NIEHS include, but are not limited to: optimizing mHealth technology to prevent or mitigate environmental exposures; development and implementation of mHealth technologies that have the potential to reduce environmental health disparities; using mHealth technology to link to existing datasets to increase access to exposure information and promote health literacy; and using mHealth technology to increase access to resources in low- and middle-income countries to mitigate the effects of climate change and other natural and human-caused disasters on human health.

Deadline: November 15, 2021

Letter of Intent: October 16, 2021

Application Due Date Dec 15 2021
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award (F99/K00 Clinical Trial Not Allowed)

 The NIH Blueprint and Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award is intended for individuals who have demonstrated an interest in a neuroscience research career in NIH Blueprint  mission-relevant areas and/or BRAIN Initiative research areas. This award will support a defined pathway across career stages for outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical and behavioral sciences. This two-phase award will facilitate completion of the doctoral dissertation, transition talented graduate students to strong neuroscience research postdoctoral positions, and will provide career development opportunities relevant to their long-term career goal of becoming independent neuroscience researchers.

Deadline:  December 15, 2021

Letter of Intent: Due 30 days prior to the application due date

Application Due Date Jan 05 2022
PHS 2021-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

 Enables U.S.-owned and operated small businesses to conduct research and development that has a strong potential for commercialization. This award and the associated PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) provide funds for small businesses to stimulate technological innovation in the private sector and strengthen the role of small business in meeting federal research and development needs. The related Small Business Technology Transfer announcements (PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) and PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42 Clinical Trial Required)) aim to foster technology transfer through cooperative research and development between small businesses and research institutions. Applicants are encouraged to submit grant applications in response to NIH-identified topics.

Deadline:  January 5, 2022

Application Due Date Feb 01 2022
Notice of Intent to Publish a Funding Opportunity Announcement for Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)

Intent to reissue a funding opportunity announcement for the ViCTER award. The ViCTER program fosters and promotes early-stage transdisciplinary collaborations and/or translational research efforts among fundamental (technology and mechanism oriented), clinical (patient-oriented), and population-based researchers in the environmental health field. This funding opportunity will use the R01 mechanism and will bring together newly established collaborative teams to investigate potential linkages between human health and one or more environmental stressor(s). The ViCTER program is intended to support innovative high-risk, high-reward cross-disciplinary and/or translational research projects that are more difficult to achieve in a typical R01 application. Collaboration is highly encouraged among investigators at different institutions through a virtual consortium arrangement. 

Deadline:  February 1, 2022

Application Due Date Feb 05 2022
Pediatric Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)

Supports research which correlates immune system in general and development patterns in particular, between two or more age groups - neonates, infants, and children and adolescents to understand the evolution or immune ontogeny in human immune system development focusing on either or both, innate and adaptive immune systems with additional focus on internal factors like the microbiome and/or external factors like the environment.

Deadline:  February 5, 2022

Application Due Date Feb 05 2022
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Supports innovative population-based research that can contribute to identifying and characterizing pathways and mechanisms through which work or occupation influences health outcomes and health status among populations with health and/or health care disparities, and how work functions as a social determinant of health. Of particular interest are projects designed to examine pathways and mechanisms using conceptual models grounded in minority health and health disparities theories that recognize that health disparities arise by multiple and overlapping contributing factors acting at multiple levels of influence. Studies must examine NIH-designated U.S. health disparities populations. NIEHS is interested in applications that focus on the intersection of work as a social determinant of health, the physical environment (that includes exposures to toxicants), and other social determinants of health in creating or intensifying environmental health disparities at the population level. Community engaged research approaches are strongly encouraged as well as applications that move the science of environmental health disparities toward achieving environmental justice for affected populations.

Deadline:  February 5, 2022

Application Due Date Mar 17 2022
Environmental Literacy Program: Increasing Community Resilience to Extreme Weather and Climate Change (NOAA Cooperative Agreement)

Supports projects that develop the collective environmental literacy necessary for communities to take actions that build resilience to extreme weather and climate change in ways that contribute to community health, social cohesion, and socio-economic equity. This funding opportunity is soliciting two types of projects through separate competitive priorities. Priority 1 awards are intended to fund new projects located in Central and Eastern Regions of the United States. Note that pre-applications are required for Priority 1 applications. Only those institutions that receive authorization from NOAA are eligible to submit a full application. Priority 2 awards will support the evolution of projects funded under the 2015-2018 funding opportunities from this program. Projects should demonstrate how they will engage children, youth, and/or adults to build these capabilities, particularly through active and social learning, during the award period. Projects should leverage and incorporate relevant state and local resilience plans and collaborate with individuals and institutions that participate in efforts to develop or implement those plans. Projects should support diversity, equity, inclusion, and climate justice in all aspects of the project.

Deadline:  March 17, 2022

Back
to Top